While the overexpression of FOXA1 and HOXB13 pushes AR cistrome to a more tumor-like profile, pioneering activity of GATA2 allows AR to bind to enhancers of metastasis and treatment resistance associated genes, thereby contributing to PCa progression. The gene discussed is FOXA1; the disease is neoplasm.